Last reviewed · How we verify
Intestinal infection due to Pseudomonas
Approved treatments
- Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Intestinal infection due to Pseudomonas patent landscape — cliff calendar, originator estates, attackable patents
- Intestinal infection due to Pseudomonas treatment landscape brief
- Intestinal infection due to Pseudomonas treatment updates RSS
Frequently asked questions about Intestinal infection due to Pseudomonas
What drugs treat Intestinal infection due to Pseudomonas?
Tracked treatments include Recarbrio.
What is the treatment for Intestinal infection due to Pseudomonas?
Standard treatment for Intestinal infection due to Pseudomonas includes Recarbrio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Intestinal infection due to Pseudomonas patent cliff · Intestinal infection due to Pseudomonas CI report
- Treatment: Recarbrio · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing